Spok to Demonstrate the Power of its Clinical Communication Platform at HIMSS22

Spok, a subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK), will showcase its healthcare communication platform, Spok Care Connect®, at HIMSS22 from March 14-18, 2022, in Orlando, Florida.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Tags

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

03/08/2022 - 09:00 AM EST

Experts will discuss new approaches to patient device association in the Interoperability Showcase™ and highlight Spok Care Connect® in booth #3321

ALEXANDRIA, Va.--(BUSINESS WIRE)-- Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a leader in healthcare communications, will explore the latest possibilities for driving meaningful change in today’s hospitals during HIMSS22. Spok solution experts will demonstrate the power of the Spok Care Connect® healthcare communication platform and the new GenA™ pager in booth #3321 throughout the conference, March 14-18, 2022, at the Orange County Convention Center in Orlando, Florida.

“HIMSS22 will give us the opportunity to reconnect with customers and prospects both in person at our booth and through the Interoperability Showcase,” said Vincent D. Kelly, president and chief executive officer of Spok Holdings, Inc. “Hospitals and health systems continue to look for intuitive ways to help clinicians and other staff members exchange information securely to close gaps in patient care. We are rededicating our focus on our advanced healthcare communication platform, Spok Care Connect, to help thousands of healthcare organizations achieve this goal.”

This year Spok also returns to the HIMSS Interoperability Showcase™ to host “Closing Gaps in Patient Device Association” in hall E, booth #8240. The exhibit will focus on balancing staffing ratios with documentation guidelines and medical equipment. Since patients and medical equipment are constantly on the move in today’s healthcare environment, establishing device associations is crucial for care continuity during patient transfers. This case will highlight how the new PCIM standard facilitates automating the association process to reduce errors and omissions.

Additionally, HIMSS22 attendees will be able to discover the new GenA™ pager, a one-way alphanumeric device that pairs advanced encryption and security with a high-resolution ePaper display. This next-generation pager is encased in an antimicrobial housing that supports strict hygiene protocols and features over-the-air programming for ease of configuration.

About Spok

Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK), headquartered in Alexandria, Virginia, is proud to be a global leader in healthcare communications. We deliver clinical information to care teams when and where it matters most to improve patient outcomes. Top hospitals rely on the Spok Care Connect® platform to enhance workflows for clinicians and support administrative compliance. Our customers send over 100 million messages each month through their Spok® solutions. When seconds count and patients’ lives are at stake, Spok enables smarter, faster clinical communication. For more information, visit spok.com or follow @spoktweets on Twitter.

Spok is a trademark of Spok Holdings, Inc. Spok Care Connect and Spok Mobile are trademarks of Spok, Inc.